Impact of PI and NNRTI HAART-based therapy on oral lesions of brazilian HIV-infected patients

Journal of Oral Pathology and Medicine

Volumn 38, Issue 6, 2009, Pages 489-494

  Ortega, Karem L ^a   Vale, Daniela A ^a   Magalhães, Marina H C G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brazil; HAART; HIV; NNRTI; Oral manifestations

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; EPIDEMIC; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; KAPOSI SARCOMA; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MOUTH EXAMINATION; MOUTH LESION; PRIORITY JOURNAL; SEROLOGY; THRUSH; VIRUS LOAD;

EID: 67650711513     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00783.x     Document Type: Article

References (47)

1. Imamichi T. Action of anti-HIV drugs and resistance: reverse transcriptase inhibitors and protease inhibitors. Curr Pharm Des 2004 10 : 4039 53.
2. Temesgen Z, Warnke D, Kasten MJ. Current status of antiretroviral therapy. Expert Opin Pharmacother 2006 7 : 1541 54.
3. Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997 277 : 112 6.
4. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997 337 : 734 9.
5. Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 1997 11 : 1731 8.
6. Aguirre JM, Echebarria MA, Ocina E, Ribacoba L, Montejo M. Reduction of HIV-associated oral lesions after highly active antiretroviral therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999 88 : 114 5.
7. Chen LF, Hoy J, Lewin SR. Ten years of highly active antiretroviral therapy for HIV infection. Med J Aust 2007 186 : 146 51.
8. Reichart P. US1 HIV - changing patterns in HAART era, patients' quality of life and occupational risks. Oral Dis 2006 12 (Suppl. 1 3.
9. Birnbaum W, Hodgson TA, Reichart PA, Sherson W, Nittayannanta SW, Axell TE. Prognostic significance of HIV-associated oral lesions and their relation to therapy. Oral Dis 2002 8 (Suppl. 2 110 4.
10. Pulvirenti JJ. Inpatient care of the HIV infected patient in the highly active antiretroviral therapy (HAART) era. Curr HIV Res 2005 3 : 133 45.
11. Ceballos-Salobrena A, Gaitan-Cepeda LA, Ceballos-Garcia L, Lezama-Del Valle D. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?. AIDS Patient Care STDS 2000 14 : 627 35.
12. Eyeson JD, Warnakulasuriya KAAS, Johnson NW. Prevalence and incidence of oral lesions - the changing scene. Oral Dis 2000 6 : 267 73.
13. Eyeson JD, Tenant-Flowers M, Cooper DJ, Johnson NW, Warnakulasuriya KAAS. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London. J Oral Pathol Med 2002 31 : 169 74.
14. Hodgson TA, Greenspan D, Greenspan JS. Oral lesions of HIV disease and HAART in industrialized countries. Adv Dent Res 2006 19 : 57 62.
15. Fethi T, Asma J, Amine SM, et al. Effects on immunological and virological outcome of patients using one protease inhibitor or one non-nucleoside reverse transcriptase inhibitor in a triple antiretroviral therapy: normal clinical practice versus clinical trial findings. Curr HIV Res 2005 3 : 271 6.
16. Bartlett JA, Fath MJ, Demasi R, et al. An updated systematic overview of triple combination therapy in antiretroviral-naive HIV-infected adults. AIDS 2006 20 : 2051 64.
17. Ramírez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Anaya-Saavedra G, González-Ramírez I, Ponce-de-León S. The changing clinical spectrum of human immunodeficiency virus (hiv)-related oral lesions in 1,000 consecutive patients: a 12-year study in a referral center in Mexico. Medicine (Baltimore) 2003 1 : 39 50. (Pubitemid 36139799)
18. UNAIDS/WHO epidemiological fact sheet on HIV/AIDS and sexually transmitted infections, 2004 update. http://data.unaids.org/Publications/Fact- Sheets01/Brazil-EN.pdf (last accessed 10 April 2009).
19. Cohen J. Brazil: ten years after. Science 2006 313 : 484 7.
20. EC Clearinghouse on Oral Problems Related to HIV Infection and WHO Collaborating Centre on Oral Manifestations of the Immunodeficiency virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993 22 : 289 91.
21. Dorrell L, Snow MH, Ong EL. Mortality and survival trends in patients with AIDS in north east England from 1984-1992. J Infect 1995 30 : 23 7.
22. Dourado I, Veras MA, Barreira D, de Brito AM. AIDS epidemic trends after the introduction of antiretroviral therapy in Brazil. Rev Saude Publica 2006 40 (Suppl. 1 9 17. (Pubitemid 43797092)
23. Pinheiro A, Marcenes W, Zakrzewska JM, Robinson PG. Dental and oral lesions in HIV infected patients: a study in Brazil. Int Dent J 2004 54 : 131 7.
24. Greenspan JS, Greenspan D. The epidemiology of the oral lesions of HIV infection in the developed world. Oral Dis 2002 8 (Suppl. 2 34 9.
25. Ranganathan K, Hemalatha R. Oral lesions in HIV infection in developing countries: an overview. Adv Dent Res 2006 19 : 63 8.
26. Patton LL, McKaig R, Strauss R, Rogers D, Eron JJ Jr. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000 89 : 299 304.
27. Gillespie GM, Marino R. Oral manifestations of HIV infection: a Pan-American perspective. J Oral Pathol Med 1993 22 : 2 7. (Pubitemid 23039839)
28. Magalhaes MG, Bueno DF, Serra E, Goncalves R. Oral manifestations of HIV-positive children. J Clin Pediatr Dent 2001 25 : 103 6.
29. Fonseca R, Cardoso AS, Pomarico I. Frequency of oral manifestations in children infected with human immunodeficiency virus. Quintessence Int 2000 31 : 419 22.
30. Santos LC, Castro GF, de Souza PI, Oliveira RH. Oral manifestations related to immunosuppression degree in HIV-positive children. Braz Dent J 2001 12 : 135 8.
31. Miziara ID, Filho BC, Weber R. Oral lesions in Brazilian HIV-infected children undergoing HAART. Int J Pediatr Otorhinolaryngol 2006 70 : 1089 96.
32. Moreira ED Jr., Silva N, Brites C, et al. Characteristics of the acquired immunodeficiency syndrome in Brazil. Am J Trop Med Hyg 1993 48 : 687 92.
33. Arendorf TM, Bredekamp B, Cloete CA, Sauer G. Oral manifestations of HIV infection in 600 South African patients. J Oral Pathol Med 1998 27 : 176 9.
34. Chidzonga MM. HIV/AIDS orofacial lesions in 156 Zimbabwean patients at referral oral and maxillofacial surgical clinics. Oral Dis 2003 9 : 317 22.
35. Hodgson TA. HIV-associated oral lesions: prevalence in Zambia. Oral Dis 1997 3 (Suppl. 1 46 50.
36. Jonsson N, Zimmerman M, Chidzonga MM, Jonsson K. Oral manifestations in 100 Zimbabwean HIV/AIDS patients referred to a specialist centre. Cent Afr J Med 1998 44 : 31 4.
37. Nittayananta W, Chungpanich S. Oral lesions in a group of Thai people with AIDS. Oral Dis 1997 3 (Suppl. 1 41 5.
38. Porter SR, Luker J, Scully C, Glover S, Griffiths MJ. Orofacial manifestations of a group of British patients infected with HIV-1. J Oral Pathol Med 1989 18 : 47 8.
39. Schulten EA, ten Kate RW, van der Waal I. Oral manifestations of HIV infection in 75 Dutch patients. J Oral Pathol Med 1989 18 : 42 6.
40. Moniaci D, Greco D, Flecchia G, Raiteri R, Sinicco A. Epidemiology, clinical features and prognostic value of HIV-1 related oral lesions. J Oral Pathol Med 1990 19 : 477 81.
41. Laskaris G, Hadjivassiliou M, Stratigos J. Oral signs and symptoms in 160 Greek HIV-infected patients. J Oral Pathol Med 1992 21 : 120 3.
42. Ceballos-Salobrena A, Aguirre-Urizar JM, Bagan-Sebastian JV. Oral manifestations associated with human immunodeficiency virus infection in a Spanish population. J Oral Pathol Med 1996 25 : 523 6.
43. Ranganathan K, Reddy BV, Kumarasamy N, Solomon S, Viswanathan R, Johnson NW. Oral lesions and conditions associated with human immunodeficiency virus infection in 300 south Indian patients. Oral Dis 2000 6 : 152 7.
44. Galvao J. Access to antiretroviral drugs in Brazil. Lancet 2002 360 : 1862 5.
45. Flint SR, Tappuni A, Leigh J, Schmidt-Westhausen AM, MacPhail L. (B3) Markers of immunodeficiency and mechanisms of HAART therapy on oral lesions. Adv Dent Res 2006 19 : 146 51.
46. Miziara ID, Weber R. Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients. Oral Dis 2006 12 : 402 7.
47. Yeni PG, Hammer SM, Hirsch MS, et al. Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society USA. JAMA 2004 292 : 251 65.